Literature DB >> 27145057

Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.

Justin D Glenn1, Ellen M Mowry1.   

Abstract

Microbiota of the human body perform fundamental tasks that contribute to normal development, health, and homeostasis and are intimately associated with numerous organ systems, including the gut. Microbes begin gut inhabitance immediately following birth and promote proper gut epithelial construction and function, metabolism and nutrition, and immune system development. Inappropriate immune recognition of self-tissue can lead to autoimmune disease, including conditions such as multiple sclerosis (MS), in which the immune system recognizes and attacks central nervous system tissue. Preclinical studies have demonstrated a requirement of gut microbiota for neuroinflammatory autoimmune disease in animal models, and a growing number of clinical investigations are finding associations between MS status and the composition of the gut microbiota. In this review, we examine current undertakings into better understanding the role of gut bacteria and their phages in MS development, review associations of the gut microbiota makeup and MS, and discuss potential mechanisms by which the gut microbiota may be manipulated for therapeutic benefit.

Entities:  

Mesh:

Year:  2016        PMID: 27145057      PMCID: PMC5118957          DOI: 10.1089/jir.2015.0177

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  103 in total

1.  Influence of mode of delivery on gut microbiota composition in seven year old children.

Authors:  S Salminen; G R Gibson; A L McCartney; E Isolauri
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

3.  Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains.

Authors:  C B Maassen; C van Holten-Neelen; F Balk; M J den Bak-Glashouwer; R J Leer; J D Laman; W J Boersma; E Claassen
Journal:  Vaccine       Date:  2000-05-22       Impact factor: 3.641

Review 4.  Immune-microbiota interactions in health and disease.

Authors:  Noah W Palm; Marcel R de Zoete; Richard A Flavell
Journal:  Clin Immunol       Date:  2015-06-30       Impact factor: 3.969

Review 5.  Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology.

Authors:  Maite Muniesa; Jens A Hammerl; Stefan Hertwig; Bernd Appel; Harald Brüssow
Journal:  Appl Environ Microbiol       Date:  2012-04-13       Impact factor: 4.792

6.  Gut microbiota in multiple sclerosis: possible influence of immunomodulators.

Authors:  Brandi L Cantarel; Emmanuelle Waubant; Christel Chehoud; Justin Kuczynski; Todd Z DeSantis; Janet Warrington; Arun Venkatesan; Claire M Fraser; Ellen M Mowry
Journal:  J Investig Med       Date:  2015-06       Impact factor: 2.895

Review 7.  Exploiting gut bacteriophages for human health.

Authors:  Marion Dalmasso; Colin Hill; R Paul Ross
Journal:  Trends Microbiol       Date:  2014-03-20       Impact factor: 17.079

8.  Bacteriophage adhering to mucus provide a non-host-derived immunity.

Authors:  Jeremy J Barr; Rita Auro; Mike Furlan; Katrine L Whiteson; Marcella L Erb; Joe Pogliano; Aleksandr Stotland; Roland Wolkowicz; Andrew S Cutting; Kelly S Doran; Peter Salamon; Merry Youle; Forest Rohwer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

9.  Geographical variations in sex ratio trends over time in multiple sclerosis.

Authors:  Maria Trojano; Guglielmo Lucchese; Giusi Graziano; Bruce V Taylor; Steve Simpson; Vito Lepore; Francois Grand'maison; Pierre Duquette; Guillermo Izquierdo; Pierre Grammond; Maria Pia Amato; Roberto Bergamaschi; Giorgio Giuliani; Cavit Boz; Raymond Hupperts; Vincent Van Pesch; Jeannette Lechner-Scott; Edgardo Cristiano; Marcela Fiol; Celia Oreja-Guevara; Maria Laura Saladino; Freek Verheul; Mark Slee; Damiano Paolicelli; Carla Tortorella; Mariangela D'Onghia; Pietro Iaffaldano; Vita Direnzo; Helmut Butzkueven
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

Review 10.  The human gut virome: a multifaceted majority.

Authors:  Lesley A Ogilvie; Brian V Jones
Journal:  Front Microbiol       Date:  2015-09-11       Impact factor: 5.640

View more
  11 in total

Review 1.  The multiple pathways to autoimmunity.

Authors:  Argyrios N Theofilopoulos; Dwight H Kono; Roberto Baccala
Journal:  Nat Immunol       Date:  2017-06-20       Impact factor: 25.606

Review 2.  Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota.

Authors:  Ward J van den Hoogen; Jon D Laman; Bert A 't Hart
Journal:  Front Immunol       Date:  2017-09-05       Impact factor: 7.561

3.  Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet.

Authors:  Alexander Swidsinski; Yvonne Dörffel; Vera Loening-Baucke; Christoph Gille; Önder Göktas; Anne Reißhauer; Jürgen Neuhaus; Karsten-Henrich Weylandt; Alexander Guschin; Markus Bock
Journal:  Front Microbiol       Date:  2017-06-28       Impact factor: 5.640

Review 4.  Implications of white matter damage in amyotrophic lateral sclerosis (Review).

Authors:  Ting Zhou; Tina Khorshid Ahmad; Kiana Gozda; Jessica Truong; Jiming Kong; Michael Namaka
Journal:  Mol Med Rep       Date:  2017-08-07       Impact factor: 2.952

Review 5.  The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View.

Authors:  Alessandro Maglione; Simona Rolla; Stefania Federica De Mercanti; Santina Cutrupi; Marinella Clerico
Journal:  Cells       Date:  2019-10-19       Impact factor: 6.600

Review 6.  Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy.

Authors:  Lin Shui; Xi Yang; Jian Li; Cheng Yi; Qin Sun; Hong Zhu
Journal:  Front Immunol       Date:  2020-01-17       Impact factor: 7.561

7.  Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study.

Authors:  Jeske van Pamelen; Lynn van Olst; Andries E Budding; Helga E de Vries; Leo H Visser
Journal:  JMIR Res Protoc       Date:  2020-07-29

Review 8.  Interrelation of Diet, Gut Microbiome, and Autoantibody Production.

Authors:  Ioanna Petta; Judith Fraussen; Veerle Somers; Markus Kleinewietfeld
Journal:  Front Immunol       Date:  2018-03-06       Impact factor: 7.561

9.  Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study.

Authors:  Marina Saresella; Laura Mendozzi; Valentina Rossi; Franca Mazzali; Federica Piancone; Francesca LaRosa; Ivana Marventano; Domenico Caputo; Giovanna E Felis; Mario Clerici
Journal:  Front Immunol       Date:  2017-10-25       Impact factor: 7.561

Review 10.  The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?

Authors:  Hannah M Kohl; Andrea R Castillo; Javier Ochoa-Repáraz
Journal:  Diseases       Date:  2020-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.